VIMAB Group AB (publ) (NM4) Stock Price & News

All values in SEK	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	93,03 m	86,58 m	67,45 m	90,88 m
Cost of goods sold	72,25 m	82,41 m	64,31 m	70,01 m
Cost of revenue	72,25 m	82,41 m	64,31 m	70,01 m
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	19,57 m	22,10 m	18,67 m	20,52 m
Operating expense	25,26 m	53,58 m	22,30 m	24,52 m
Total operating expenses	97,51 m	135,99 m	86,62 m	94,53 m
Operating income	-4,47 m	-49,42 m	-19,17 m	-3,65 m
Other non operating income	745,00 k	-8,65 m	815,00 k	1,28 m
EBT including unusual items	-5,03 m	-55,09 m	-21,85 m	-3,19 m
EBT excluding unusual items	-5,03 m	-62,34 m	-21,85 m	-8,24 m
Income tax expense	-	-505,00 k	-	-
Effective tax rate	-	0,92%	-	-
Other operating expenses	-500,00 k	8,74 m	-2,03 m	-1,52 m
Net income	-5,03 m	-54,58 m	-21,85 m	-3,19 m
Net profit margin	-5,41%	-63,05%	-32,39%	-3,51%
Earnings per share	-	-	-	-
Interest and investment income	-	39,00 k	-	-
Interest expense	-1,31 m	-4,59 m	-3,50 m	-5,87 m
Net interest expenses	-1,31 m	-4,55 m	-3,50 m	-5,87 m
Depreciation and amortization charges	6,19 m	22,74 m	5,67 m	5,53 m
EBITDA	1,71 m	-39,01 m	-13,50 m	1,88 m
Gain or loss from assets sale	-	13,11 m	-	-

Finance